ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy

October 27, 1978

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003